US EditionPfizer warns FDA of shrinking penicillin supply
- Pfizer warned that it will run out of several doses of penicillin that treat syphilis, strep throat, and other infections later this year due to supply chain shortages in the US.
- The company anticipates running out of the children's dose of the syphilis drug Bicillin L-A by the end of June and that a different penicillin, Bicillin C-R, is expected to run out in the third quarter.
Insights by Ground AI
Does this summary seem wrong?
12 Articles
12 Articles
All
Left
1
Center
9
Right
2
Pfizer warns FDA of shrinking penicillin supply
(The Hill) -- The ongoing drug shortages impacting the U.S. are now threatening to exhaust two commonly used forms of penicillin, Pfizer said in a warning to the Food and Drug Administration (FDA) on Monday. Pfizer alerted the FDA that there is "a limited supply and impending stock out" of Bicillin L-A and Bicillin C-R, two of its injectable penicillin products. Get the latest, news, weather, sports and community events delivered right to y…
·Albany, United States
Read Full ArticleCoverage Details
Total News Sources12
Leaning Left1Leaning Right2Center9Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
C 75%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
